Literature DB >> 10700725

Steroidogenic acute regulatory protein mRNA expression in adrenal tumours.

S Zenkert1, B Schubert, M Fassnacht, F Beuschlein, B Allolio, M Reincke.   

Abstract

The rate limiting step in steroidogenesis is cholesterol transport through the outer to the inner mitochondrial membrane and the cytochrome P450 side chain cleavage (P450scc) complex. The protein factor responsible for this transport, and as such necessary for regulating the acute production of steroids, has been identified and named the steroidogenic acute regulatory protein (StAR). We investigated the expression of StAR in functional and non-functional adrenal neoplasms and compared the expression with that of P450scc. Poly A RNA was extracted from normal adrenal glands (NAG, n=5), aldosterone producing adenomas (APA, n=4), cortisol producing adenomas (CPA, n=5), adrenocortical carcinomas (ACC, n=6) and non-functional adenomas (NFA, n=3), electrophoresed through a 1% agarose gel, blotted and hybridised with a PCR-generated cDNA labelled with [(32)P]CTP. The blots were stripped and re-hybridised with a P450scc cDNA and a mouse beta-actin probe. Compared with P450scc, StAR mRNA expression showed little variability in the magnitude of expression and did not correlate with the endocrine profiles (NAG: StAR 100+/-16%, P450scc 100+/-14%; APA: StAR 80+/-3%, P450scc 94+/-13%; CPA: StAR 71+/-10%, P450scc 109+/-15%; NFA: StAR 64+/-9.5%, P450scc 18+/-5%; means+/-s.e.m.). ACC expressed low levels of both genes probably as a result of dedifferentiation (StAR 29+/-9%, P450scc 46+/-18%). Incubation of the NCI-h295 tumour cell line with 10nmol ACTH and 10micromol forskolin induced an increase in the abundance of StAR and P450scc mRNA, demonstrating gene regulation by the cAMP protein kinase A pathway. Furthermore, we incubated the NCI-h295 tumour cell line with the adrenostatic compounds, aminoglutethimide and metyrapone. We could not detect an effect on the expression of StAR mRNA, whereas the expression of P450scc mRNA was significantly reduced. We conclude that, in contrast to P450scc, StAR seems to be evenly expressed in adrenocortical adenomas. Therefore, the endocrine activity of a given tumour cannot be explained by the abundance of StAR expression. In ACC, both StAR and P450scc expression is low, explaining the relatively inefficient steroid production of these tumours.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10700725     DOI: 10.1530/eje.0.1420294

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  4 in total

Review 1.  The challenge of developmental therapeutics for adrenocortical carcinoma.

Authors:  Ricardo Costa; Benedito A Carneiro; Fabio Tavora; Sachin G Pai; Jason B Kaplan; Young Kwang Chae; Sunandana Chandra; Peter A Kopp; Francis J Giles
Journal:  Oncotarget       Date:  2016-07-19

2.  The emerging role of the molecular marker p27 in the differential diagnosis of adrenocortical tumors.

Authors:  Sofia S Pereira; Tiago Morais; Madalena M Costa; Mariana P Monteiro; Duarte Pignatelli
Journal:  Endocr Connect       Date:  2013-08-28       Impact factor: 3.335

3.  Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors.

Authors:  Gerald Goh; Ute I Scholl; James M Healy; Murim Choi; Manju L Prasad; Carol Nelson-Williams; John W Kunstman; John W Kuntsman; Reju Korah; Anna-Carinna Suttorp; Dimo Dietrich; Matthias Haase; Holger S Willenberg; Peter Stålberg; Per Hellman; Göran Akerström; Peyman Björklund; Tobias Carling; Richard P Lifton
Journal:  Nat Genet       Date:  2014-04-20       Impact factor: 38.330

Review 4.  The Immunotherapy Landscape in Adrenocortical Cancer.

Authors:  Guillaume J Pegna; Nitin Roper; Rosandra N Kaplan; Emily Bergsland; Katja Kiseljak-Vassiliades; Mouhammed Amir Habra; Yves Pommier; Jaydira Del Rivero
Journal:  Cancers (Basel)       Date:  2021-05-28       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.